Ann: Deferral of FDA consideration of enforcement discretion, page-100

First 100 Last

Share
Profile

Follow
jossette

775 Posts.

139

10/08/22

12:26

Post #: 63031402
Share

Originally posted by werdplaya58: ↑

Thanks, very useful article for getting a read on the situation. Few interesting quotes that give some credibility to your interpretation.

As you stated correctly, the A2 committed 1M tins towards this:

"The a2 Milk Company stands ready to aid U.S. families and their babies during this critical shortage of products with high-quality infant formula both in the short and long term,” says Blake Waltrip, U.S. CEO for The a2 Milk Company. “We have 1 million tins (approximately 27 million 8-oz. servings) committed through the end of the November discretionary period and one of the largest capacities to provide long-term benefit.”

And it is dubious whether some of the other approved suppliers can deliver the quantities they promised:

"U.K.-based Global Kosher was supposed to be more than a quarter of FDA’s 18.4 million can total. Just last week the agency suspended Global Kosher’s enforcement discretion saying it had submitted altered paperwork."

"Now that Global Kosher 4.8 million cans have been suspended, Care A2+ has the remaining single largest quantity promised, also at 4.875 million cans. It’s an opportunity potentially worth millions of dollars in U.S. sales. However, according to IRI, the 2021 startup sold slightly more than $164,000 worth of product (retail value sales) in the 12 months ending June 2022 to Australian grocery and pharmacies. The prior year to it was $31,450 in retail sales values. It’s a fraction of the volume promised to the U.S. market."

So, I don't think your interpretation is crazy at all. However, it has to be squared with the fact that the shortages appear to have eased at least somewhat, and that A2M CEO has come out and expressed disappointment about the deferral (which suggests they are not confident either). It's clear to me the FDA is a total shambles, so anything is possible at this point.

Expand

hI Werds,

the current short term FDA opportunity is worth circa NZD$25- 27 million in sales (1 million tins) and $5-6 million in profit( less any extra over overheads). Not a game changer by any means.

the big kicker is if FDA grants permanent access and A2 would be able to sell IF ongoing, you could see this growing to 5 million tins a year business i.e NZD$125-150 million sales and $25-30 million in profit.

A2M Price at posting: $4.69 Sentiment: Buy Disclosure: Held
6 Upvote

0 Great analysis

Reply

Top Stories

BGL

Bellevue aims for 45% production increase by FY 2028, announces $150M placement

MM1

Geochemical work at Newington picks up gold and copper anomalies for Midas

Capital raisings wrap: Brainchip, Ovanti, Lake and VHM

PEC

Perpetual sniffs TREOs beyond 4000ppm at Raptor play in Brazil

TRP

Tissue Repairs soars nearly 32% on TGA approval for wound healing gel

There are more pages in this discussion • 42 more messages in this thread...

First 100 Last

Add A2M (ASX) to my watchlist

(20min delay)
Last $6.91		Change 0.040(0.58%)		Mkt cap ! $4.995B

Open	High	Low	Value	Volume
$6.87	$6.94	$6.82	$13.46M	1.954M

Buyers (Bids)

No.	Vol.	Price($)
3	8562	$6.87

Sellers (Offers)

Price($)	Vol.	No.
$6.92	3312	2

View Market Depth

No.	Vol.	Price($)
3	8562	6.870
1	5250	6.860
2	15431	6.850
1	4203	6.840
1	146	6.800

Price($)	Vol.	No.
6.920	3312	2
6.930	204	1
6.950	1200	2
6.970	3000	2
6.980	20006	3

Last trade - 16.10pm 25/07/2024 (20 minute delay)

A2M (ASX) Chart

Ann: Deferral of FDA consideration of enforcement discretion, page-100

Bellevue aims for 45% production increase by FY 2028, announces $150M placement

Geochemical work at Newington picks up gold and copper anomalies for Midas

Capital raisings wrap: Brainchip, Ovanti, Lake and VHM

Perpetual sniffs TREOs beyond 4000ppm at Raptor play in Brazil

Tissue Repairs soars nearly 32% on TGA approval for wound healing gel

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Deferral of FDA consideration of enforcement discretion, page-100

Top Stories

Bellevue aims for 45% production increase by FY 2028, announces $150M placement

Geochemical work at Newington picks up gold and copper anomalies for Midas

Capital raisings wrap: Brainchip, Ovanti, Lake and VHM

Perpetual sniffs TREOs beyond 4000ppm at Raptor play in Brazil

Tissue Repairs soars nearly 32% on TGA approval for wound healing gel

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News